Diet Exercise and ARmodafinil for obstructive sleep apnea (OSA) patients who cannot use standard treatments. (DEAR)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1038709

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Obstructive sleep apnea (OSA) affects over 3.5 million Australians and is associated with marked daytime sleepiness and decreased concentration. It is also a common health complication of obesity. Many people are unable to use standard treatments for OSA in the form of a mouth splint or mask worn at night. This study will look at treating the daytime sleepiness with a stimulant medication, Armodafinil, whilst reducing OSA severity gradually with diet and lifestyle modification.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2015

Funding Scheme: Postgraduate Scholarships

Funding Amount: $95,313.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

clinical trial | neurocognitive assessment | pharmacological intervention | quality of life | sleep apnoea | weight control

Related Links